Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
SIB Swiss Institute of Bioinformatics | RCV000515616 | SCV000787493 | uncertain significance | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | 2018-04-16 | criteria provided, single submitter | curation | This variant is interpreted as a Uncertain Significance, for 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome, Autosomal Recessive inheritance. The following ACMG Tag(s) were applied: PM2 => Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PP3 => Multiple lines of computational evidence support a deleterious effect on the gene or gene product. |
Yoda Diagnostics Pvt Ltd, |
RCV000515616 | SCV000537858 | pathogenic | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | no assertion criteria provided | research | The homozygous for this variant was a 11 year-old female child with severe and increasing dystonia. Patient had difficulty in walking and ataxia, which progressed to severe dystonia, wry neck, dysarthria, and drooling. | |
OMIM | RCV000515616 | SCV002016241 | pathogenic | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | 2021-11-17 | no assertion criteria provided | literature only |